SYNTHORX
Summary
Synthorx is a clinical-stage biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 1.90 B
Avg. Deal Size£ 1.90 B
All rights reserved. Copyright © 2025 Datasite
